graf 3dcellculture assists enterprises, research institutions and individual persons in in the field of 3D cell culture, it’s technologies and applications. Human three-dimensional tissue models promise new opportunities for applications in Pharma, Medicine and Clinical Care. We use our considerable experience and inherent networking ability to assist in defining optimal technologies and the best scientific and strategic direction for the implementation of ideas and concepts.

graf 3dcellculture offers the following services:

• Scientific expertise in the field of 3D tissues, technologies of production and characterization and the implementation of standard applications
• Coaching and consulting in scientific and strategic focus, with the aim of reaching a successful position within a specific market
• Assistance in attracting funding
• Assistance in identifying and finding suitable partners having the requisite competencies
• Project organization and management
• Supervision of strategic development, giving inputs of knowledge and experience
• Assistance in the support of start-up companies and SMEs
• Lectures, custom-made basic and advanced education courses for groups with special interests
• Organization of meetings and symposia in the field of 3D cell culture
• Evaluation of alternative test methods replacing animal experiments including assessments of their relevant implementation
• Mentoring of persons to their career path, with emphasis given to women aspiring to leadership roles

Services

Concept development of a new Bachelor course of study at ZHAW in Biomedical Laboratory Diagnostics unique in Switzerland - from zero to implementation 2022.

Initialising and heading-up of the Competence Centre TEDD including the initiation of network projects, organisation and realization of workshops and symposia. www.icbc.zhaw.ch/tedd, TEDD-publikations

Member of the External Advisory Board of NCCR (National Center of Competence in Research) Bio-inspired Materials at the university of Fribourg. bioinspired-materials.ch

Founder member and vice president of biotechnet Switzerland and management board member of National Thematic Network NTN Swiss Biotech. Both research organisations are funded and supported by CTI (the Swiss Federal Commission for Technology and Innovation). www.biotechnet.ch, www.swissbiotech.org

Scientific board member for 3D cell culture and organization in the German association Dechema. This body convenes an international symposium on 3D cell culture every two years. dechema.de/3DCC2016.html

Course instructor for 3D cell culture-based assays for drug discovery and development during the SLAS conference in USA (Society for Lab Automation and Screening, www.slas.org) www.slas2016.org/program/shortcourses.cfm

Management board member of the association genisuisse Zürich/Ostschweiz, coaching of start-up entrepreneurs. Genilem is the leading Swiss organisation supporting innovative start-up entrepreneurs.  www.genisuisse.ch

Advisory board member of the graduate school „3D Models for Studying Microbial Infections by Human Pathogens” at the University of Würzburg, Germany. This graduate course is presently being set up.

Member of the selection panel naming the awardees of Heuberger Winterthur Jungunternehmerpreis.

Member of the foundation council of Animalfree Research. The foundation advocates the research avoiding animal experiments. www.animalfree-research.org/de/home.html

Administrative Board member of the company Mesin AG 1981 to 1993 by when the company was successfully sold.

Prof. Graf-Hausner succeeded in integrating suitable partners from industry and research with the aim of initiating successful network projects, and attracting financial support. She managed these projects through to finalization and to the provision of a reliable applications. Her network includes national and international research institutions comprising basic, applied and clinical research and technology companies, SMEs and large enterprises in the pharma and cosmetic industry. These partners cover the complete value chain.